AU:CHM Stock Latest News
Company AnnouncementsChimeric Therapeutics Reports Lapse of Performance Rights and Options2d agoCHM
Company AnnouncementsChimeric Therapeutics Halts CHM-2101 CAR-T Trial After Safety Concerns3d agoCHM
Company AnnouncementsMagellan exits substantial holding in Chimeric Therapeutics3w agoCHM
Company AnnouncementsChimeric Therapeutics Discloses Final Director Interest as Lesley Russell Departs Board3w agoCHM- Company AnnouncementsChimeric Therapeutics Announces Departure of Director Without Shareholdings3w agoCHM
Company AnnouncementsChimeric Therapeutics Names New Director, Grants 500,000 Options3w agoCHMCompany AnnouncementsChimeric Therapeutics Suspended as It Negotiates Creditor Deals and Board Restructure1M agoCHM
Company AnnouncementsChimeric Therapeutics Seeks Quotation for 22.2 Million New Shares on ASX1M agoCHM- Company AnnouncementsChimeric Therapeutics Seeks ASX Quotation for 14.8 Million New Shares1M agoCHM
Company AnnouncementsChimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities2M agoCHM
Company AnnouncementsChimeric Therapeutics Seeks ASX Quotation for 9.5 Million New Shares2M agoCHM
Company AnnouncementsChimeric Therapeutics Halts Trading Ahead of CDH17 Trial Results2M agoCHMCompany AnnouncementsChimeric Therapeutics Seeks Quotation of 1.85 Million New Shares on ASX2M agoCHM
Company AnnouncementsChimeric Therapeutics Reports Positive Trial Data and Launches Strategic Review3M agoCHM
Company AnnouncementsChimeric Flags Clinical and Regulatory Risks in Forward-Looking Disclaimer3M agoCHM
Company AnnouncementsChimeric Therapeutics Seeks ASX Quotation for 1.55m New Shares3M agoCHM
Company AnnouncementsChimeric Therapeutics Seeks ASX Quotation for Additional Shares3M agoCHM
Company AnnouncementsChimeric Therapeutics Reports Expiry of 45,000 Unexercised Options3M agoCHMCompany AnnouncementsChimeric Therapeutics Details Director Exit and Post-Consolidation Option Holdings3M agoCHM
